BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36098029)

  • 41. Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus.
    Kurozumi A; Okada Y; Mita T; Wakasugi S; Katakami N; Yoshii H; Kanda K; Nishida K; Mine S; Tanaka Y; Gosho M; Shimomura I; Watada H
    Diabetes Res Clin Pract; 2022 Apr; 186():109836. PubMed ID: 35314256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus.
    Lee DY; Kim N; Jung I; Park SY; Yu JH; Seo JA; Kim J; Kim KJ; Kim NH; Yoo HJ; Kim SG; Choi KM; Baik SH; Park SM; Kim NH
    Diabetes Metab J; 2023 Nov; 47(6):826-836. PubMed ID: 37614025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes.
    Mita T; Katakami N; Okada Y; Yoshii H; Osonoi T; Nishida K; Shiraiwa T; Kurozumi A; Taya N; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H
    Diabetologia; 2023 Dec; 66(12):2356-2367. PubMed ID: 37750893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring.
    Wang Y; Li S; Lu J; Feng K; Huang X; Hu F; Sun M; Zou Y; Li Y; Huang W; Zhou J
    Diabetologia; 2024 Jul; 67(7):1295-1303. PubMed ID: 38568252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-sectional association of metrics derived from continuous glucose monitoring with cognitive performance in older adults with type 2 diabetes.
    Sugimoto T; Tokuda H; Miura H; Kawashima S; Ando T; Kuroda Y; Matsumoto N; Fujita K; Uchida K; Kishino Y; Sakurai T
    Diabetes Obes Metab; 2023 Jan; 25(1):222-228. PubMed ID: 36082514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Continuous Glucose Monitoring Metrics With Pregnancy Outcomes in Patients With Preexisting Diabetes.
    Sanusi AA; Xue Y; McIlwraith C; Howard H; Brocato BE; Casey B; Szychowski JM; Battarbee AN
    Diabetes Care; 2024 Jan; 47(1):89-96. PubMed ID: 37782847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of the CGM metric of time in range in children and adolescents with type 1 diabetes.
    Urakami T
    Endocr J; 2022 Sep; 69(9):1035-1042. PubMed ID: 36002301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters.
    Murphy HR
    Diabetologia; 2019 Jul; 62(7):1123-1128. PubMed ID: 31161344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Achieving the HbA1c Target Requires Longer Time in Range in Pregnant Women With Type 1 Diabetes.
    Ling P; Yang D; Gu N; Xiao X; Lu J; Liu F; Zhou Z; Huang Q; Zhao J; Zhang M; Hu J; Luo S; Weng J; Yan J; Zheng X
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4309-e4317. PubMed ID: 34244734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
    Beck RW; Bergenstal RM; Cheng P; Kollman C; Carlson AL; Johnson ML; Rodbard D
    J Diabetes Sci Technol; 2019 Jul; 13(4):614-626. PubMed ID: 30636519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
    Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
    Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automated insulin delivery among adults with type 1 diabetes for up to 2 years: a real-world, multicentre study.
    Donaldson LE; Fourlanos S; Vogrin S; MacIsaac RJ; Colman PG; McAuley SA
    Intern Med J; 2024 Jan; 54(1):121-128. PubMed ID: 37255209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial.
    Beardsall K; Thomson L; Guy C; Iglesias-Platas I; van Weissenbruch MM; Bond S; Allison A; Kim S; Petrou S; Pantaleo B; Hovorka R; Dunger D;
    Lancet Child Adolesc Health; 2021 Apr; 5(4):265-273. PubMed ID: 33577770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management.
    Kong APS; Lim S; Yoo SH; Ji L; Chen L; Bao Y; Yeoh E; Chan SP; Wang CY; Mohan V; Cohen N; McGill MJ; Twigg SM
    Diabetes Res Clin Pract; 2023 Jul; 201():110718. PubMed ID: 37196707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk Factor Analysis for Type 2 Diabetes Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study.
    Uemura F; Okada Y; Mita T; Torimoto K; Wakasugi S; Katakami N; Yoshii H; Matsushita K; Nishida K; Inokuchi N; Tanaka Y; Gosho M; Shimomura I; Watada H
    Diabetes Technol Ther; 2022 Jun; 24(6):435-445. PubMed ID: 35049378
    [No Abstract]   [Full Text] [Related]  

  • 57. Glucose Levels and Risk of Frailty.
    Zaslavsky O; Walker RL; Crane PK; Gray SL; Larson EB
    J Gerontol A Biol Sci Med Sci; 2016 Sep; 71(9):1223-9. PubMed ID: 26933160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous Glucose Monitoring Time-in-Range and HbA
    Tundidor D; Meek CL; Yamamoto J; Martínez-Bru C; Gich I; Feig DS; Murphy HR; Corcoy R;
    Diabetes Technol Ther; 2021 Oct; 23(10):710-714. PubMed ID: 33945304
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.